NYSE · Health Care

TENET HEALTHCARE CORP THC

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Hospital/Nursing Management

Company profile

Business mix

  • The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
  • The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services.
  • In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology.
  • Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals.

Current key questions

  • Can the company's products, services, or pipeline expand adoption within medical care facilities?
  • How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
  • Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
Holders 3 Current sample portfolio
Public mentions 0 Videos / interviews / letters
Valuation snapshot
PE 8.47 FCF 23.99% Buyback 7.78%
2026-06-07

Current firm holders

Firm Weight Value Filing period
Lone Pine Capital Stephen Mandel 3.4% $426.2M 2026-03-31
Glenview Capital Management Larry Robbins 7.2% $287.8M 2026-03-31
Eminence Capital Ricky Sandler 3.4% $149.1M 2026-03-31

Recent trading changes over the last 2 quarters

Net buyers 2 Last 2 13F filing periods
Net reducers 2 Last 2 13F filing periods
Unchanged holders 0 Share count unchanged
Increase amount $441.6M Estimated from net added shares
Reduction amount $211.0M Estimated from net reduced shares
Net share change / base shares +35.8% +1,227,907 / 3,433,129
Lone Pine Capital Stephen Mandel 2 filing periods
13F 2025-12-31 Filed 2026-02-17
New Shares - 13F value change +$355.2M
13F 2026-03-31 Filed 2026-05-15
Major increase Shares 26.4% 13F value change +$71.1M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 0 Last 2 periods +2,258,717 (New) Total shares 2,258,717 Value $426.2M
Glenview Capital Management Larry Robbins 2 filing periods
13F 2025-12-31 Filed 2026-02-17
Minor reduction Shares -14.6% 13F value change -$77.6M
13F 2026-03-31 Filed 2026-05-15
Major reduction Shares -23.1% 13F value change -$106.5M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 2,323,679 Last 2 periods -798,825 (-34.4%) Total shares 1,524,854 Value $287.8M
Eminence Capital Ricky Sandler 2 filing periods
13F 2025-12-31 Filed 2026-02-17
Major reduction Shares -44.7% 13F value change -$103.3M
13F 2026-03-31 Filed 2026-05-15
Major increase Shares 28.7% 13F value change +$27.1M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 1,109,450 Last 2 periods -319,148 (-28.8%) Total shares 790,302 Value $149.1M
Bridgewater Associates Ray Dalio 2 filing periods
13F 2025-03-31 Filed 2025-05-14
New Shares - 13F value change +$26.9M
13F 2025-06-30 Filed 2025-08-13
Major reduction Shares -56.4% 13F value change -$11.6M
Settlement As of 13F 2025-06-30 · Filed 2025-08-13
Base shares 0 Last 2 periods +87,163 (New) Total shares 87,163 Value $15.3M

Recent mentions

No public mentions.